Bluejay Diagnostics Shares Resume Trading; Up 69%
Portfolio Pulse from Benzinga Newsdesk
Shares of Bluejay Diagnostics (BJDX) have resumed trading and are up by 69%.
July 28, 2023 | 1:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bluejay Diagnostics' shares have resumed trading and have seen a significant increase of 69%.
The resumption of trading for Bluejay Diagnostics' shares and the significant increase in its stock price directly impacts the company's market value. Investors who hold or are interested in BJDX should take note of this substantial price movement.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100